Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 426

1.

Phytosomal curcumin elicits anti-tumor properties through suppression of angiogenesis, cell proliferation and induction of oxidative stress in colorectal cancer.

Moradi-Marjaneh R, Hassanian SM, Rahmani F, Aghaee-Bakhtiari SH, Avan A, Khazaei M.

Curr Pharm Des. 2019 Jan 10. doi: 10.2174/1381612825666190110145151. [Epub ahead of print]

PMID:
30636578
2.

Apically targeted oral micelles exhibit highly efficient intestinal uptake and oral absorption.

Wang J, Wang L, Li Y, Wang X, Tu P.

Int J Nanomedicine. 2018 Nov 26;13:7997-8012. doi: 10.2147/IJN.S183796. eCollection 2018.

3.

A Biodegradable Stent with Surface Functionalization of Combined-Therapy Drugs for Colorectal Cancer.

Xie X, Zheng X, Han Z, Chen Y, Zheng Z, Zheng B, He X, Wang Y, Kaplan DL, Li Y, Li G, Wang X, Lan P.

Adv Healthc Mater. 2018 Dec;7(24):e1801213. doi: 10.1002/adhm.201801213. Epub 2018 Nov 23.

PMID:
30468567
4.

Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment.

Sesarman A, Tefas L, Sylvester B, Licarete E, Rauca V, Luput L, Patras L, Porav S, Banciu M, Porfire A.

Drug Deliv Transl Res. 2019 Feb;9(1):260-272. doi: 10.1007/s13346-018-00598-8.

PMID:
30421392
5.

Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.

Alkhader E, Roberts CJ, Rosli R, Yuen KH, Seow EK, Lee YZ, Billa N.

J Biomater Sci Polym Ed. 2018 Dec;29(18):2281-2298. doi: 10.1080/09205063.2018.1541500. Epub 2018 Dec 28.

PMID:
30376409
6.

Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT‑8/5‑Fu human colorectal cancer cell line.

Zhang C, He LJ, Ye HZ, Liu DF, Zhu YB, Miao DD, Zhang SP, Chen YY, Jia YW, Shen J, Liu XP.

Mol Med Rep. 2018 Dec;18(6):5409-5416. doi: 10.3892/mmr.2018.9589. Epub 2018 Oct 24.

7.

A W/O emulsion mediated film dispersion method for curcumin encapsulated pH-sensitive liposomes in the colon tumor treatment.

Chen Y, Du Q, Guo Q, Huang J, Liu L, Shen X, Peng J.

Drug Dev Ind Pharm. 2018 Nov 21:1-10. doi: 10.1080/03639045.2018.1539099. [Epub ahead of print]

PMID:
30346842
8.

Curcumin Induces Autophagy via Inhibition of Yes-Associated Protein (YAP) in Human Colon Cancer Cells.

Zhu J, Zhao B, Xiong P, Wang C, Zhang J, Tian X, Huang Y.

Med Sci Monit. 2018 Oct 3;24:7035-7042. doi: 10.12659/MSM.910650.

9.

Chitosan/alginate nanoparticles as a promising approach for oral delivery of curcumin diglutaric acid for cancer treatment.

Sorasitthiyanukarn FN, Muangnoi C, Ratnatilaka Na Bhuket P, Rojsitthisak P, Rojsitthisak P.

Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:178-190. doi: 10.1016/j.msec.2018.07.069. Epub 2018 Jul 25.

PMID:
30274050
10.

A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer.

Ravindranathan P, Pasham D, Balaji U, Cardenas J, Gu J, Toden S, Goel A.

Sci Rep. 2018 Sep 14;8(1):13869. doi: 10.1038/s41598-018-32267-8.

11.

Site-directed non-covalent polymer-drug complexes for inflammatory bowel disease (IBD): Formulation development, characterization and pharmacological evaluation.

Kesharwani SS, Ahmad R, Bakkari MA, Rajput MKS, Dachineni R, Valiveti CK, Kapur S, Jayarama Bhat G, Singh AB, Tummala H.

J Control Release. 2018 Nov 28;290:165-179. doi: 10.1016/j.jconrel.2018.08.004. Epub 2018 Aug 21.

PMID:
30142410
12.

Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo.

Li M, Yue GG, Tsui SK, Fung KP, Lau CB.

Phytomedicine. 2018 Jul 15;46:131-141. doi: 10.1016/j.phymed.2018.03.065. Epub 2018 Apr 3.

PMID:
30097113
13.

Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model.

Girardi B, Principi M, Pricci M, Giorgio F, Iannone A, Losurdo G, Ierardi E, Di Leo A, Barone M.

Carcinogenesis. 2018 Oct 8;39(10):1274-1282. doi: 10.1093/carcin/bgy104.

PMID:
30084990
14.

Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor Activity.

Laali KK, Greves WJ, Zwarycz AT, Correa Smits SJ, Troendle FJ, Borosky GL, Akhtar S, Manna A, Paulus A, Chanan-Khan A, Nukaya M, Kennedy GD.

ChemMedChem. 2018 Sep 19;13(18):1895-1908. doi: 10.1002/cmdc.201800320. Epub 2018 Aug 5.

PMID:
30079563
15.

Heat shock protein 27 influences the anti-cancer effect of curcumin in colon cancer cells through ROS production and autophagy activation.

Liang HH, Huang CY, Chou CW, Makondi PT, Huang MT, Wei PL, Chang YJ.

Life Sci. 2018 Sep 15;209:43-51. doi: 10.1016/j.lfs.2018.07.047. Epub 2018 Jul 27.

PMID:
30056019
16.

Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma.

Alibolandi M, Hoseini F, Mohammadi M, Ramezani P, Einafshar E, Taghdisi SM, Ramezani M, Abnous K.

Int J Pharm. 2018 Oct 5;549(1-2):67-75. doi: 10.1016/j.ijpharm.2018.07.052. Epub 2018 Jul 23.

PMID:
30048777
17.

The Curcumin Analog CH-5 Exerts Anticancer Effects in Human Osteosarcoma Cells via Modulation of Transcription Factors p53/Sp1.

Lima FT, Seba V, Silva G, Torrezan GS, Polaquini CR, Pinhanelli VC, Baek SJ, Fachin AL, Regasini LO, Marins M.

Int J Mol Sci. 2018 Jun 29;19(7). pii: E1909. doi: 10.3390/ijms19071909.

18.

Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.

Su P, Yang Y, Wang G, Chen X, Ju Y.

Int J Oncol. 2018 Sep;53(3):1343-1353. doi: 10.3892/ijo.2018.4461. Epub 2018 Jun 29.

PMID:
29956726
19.

Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1.

Lee YH, Song NY, Suh J, Kim DH, Kim W, Ann J, Lee J, Baek JH, Na HK, Surh YJ.

Cancer Lett. 2018 Sep 1;431:219-229. doi: 10.1016/j.canlet.2018.05.036. Epub 2018 May 26.

PMID:
29807115
20.

Efficacy and Safety of Curcumin in Treatment of Intestinal Adenomas in Patients With Familial Adenomatous Polyposis.

Cruz-Correa M, Hylind LM, Marrero JH, Zahurak ML, Murray-Stewart T, Casero RA Jr, Montgomery EA, Iacobuzio-Donahue C, Brosens LA, Offerhaus GJ, Umar A, Rodriguez LM, Giardiello FM.

Gastroenterology. 2018 Sep;155(3):668-673. doi: 10.1053/j.gastro.2018.05.031. Epub 2018 May 23.

PMID:
29802852

Supplemental Content

Loading ...
Support Center